Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 164, Issue 3, pp 304–307 | Cite as

Extension of the Metabolic Syndrome Cluster

  • S. I. Kseneva
  • E. V. Borodulina
  • V. V. Udut
Article

In a one-stage cross-sectional study, a continuous sample of 102 patients (mean age 47.81±0.63 years) with metabolic syndrome was examined. It was found that autonomic dysfunction determines specific features of arterial hypertension in this group of patients, it causes cardiac autonomic neuropathy and underlies the mechanisms of lower urinary tract symptoms development.

Key Words

metabolic syndrome cardiac autonomic neuropathy lower urinary tract symptoms 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Babunts IV, Miridzhanyan EM, Mashaekh YuA. Alphabet of the Analysis oh Heart Rate Variability. Moscow, 2011. Russian.Google Scholar
  2. 2.
    Vertkin AL, Zairat’yants OV, Zvyagintseva EI, Adonina EV, Lukashov MI, Lyubshina OV, Aristrakhova OYu, Gurgenidze MT, Shamuilova MM, Mikaberidze EN. Metabolic syndrome in the cardiovascular continuum. Lech. Vrach. 2008(3):71-77. Russian.Google Scholar
  3. 3.
    Udut VV, Kseneva SI, Borodulina EV, Trifonova OY. Patent RU No. 2585741. Method for early diagnosis of autonomic cardiac neuropathy in patients with arterial hypertension and metabolic disorders. Bull. No. 16. Published June 10, 2016.Google Scholar
  4. 4.
    Sakovets TG. Diabetic autonomic neuropathy as a risk factor for emergencies. Kazan. Med. Zh. 2016;97(6):931-934. Russian.CrossRefGoogle Scholar
  5. 5.
    Tyuzikov IA, Martov AG, Grekov EA. The correlation of metabolic syndrome components and hormonal disorders in prostate diseases pathogenesis. Eksper. Klin. Urol. 2012(3):39-47. Russian.Google Scholar
  6. 6.
    Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93(5):1043-1065.Google Scholar
  7. 7.
    Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Imai Y. Prognostic significance of blood pressure and heart rate varisbilities: the Ohasama Study. Hypertension. 2000;36(5):901-906.CrossRefPubMedGoogle Scholar
  8. 8.
    McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006;97(Suppl. 2):23-28.CrossRefPubMedGoogle Scholar
  9. 9.
    Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, Ferrario M, Mancia G. Blood pressure variability and organ damage in a general population: results from the PAMELA Study. Hypertension. 2002;39(2, Pt 2):710-714.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • S. I. Kseneva
    • 1
  • E. V. Borodulina
    • 1
  • V. V. Udut
    • 1
    • 2
  1. 1.E. D. Goldberg Research Institute of Pharmacology and Regenerative MedicineTomsk Research Medical Center of the Russian Academy of SciencesTomskRussia
  2. 2.National Research Tomsk State UniversityTomskRussia

Personalised recommendations